Ibsrela
Payments companies reported to CMS as associated with Ibsrela. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ibsrela, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ibsrela
These are the largest totals companies reported as associated with Ibsrela. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Darren Brenner | Chicago, IL | Gastroenterology (Internal Medicine) | $145,550.94 |
| Kavita Kongara | Atlanta, GA | Gastroenterology (Internal Medicine) | $138,371.50 |
| Satish Rao | Augusta, GA | Gastroenterology (Internal Medicine) | $138,370.12 |
| Gregory Sayuk | Saint Louis, MO | Gastroenterology (Internal Medicine) | $91,435.03 |
| Philip Schoenfeld | Ann Arbor, MI | Gastroenterology (Internal Medicine) | $90,779.84 |
| Brooks Cash | Houston, TX | Gastroenterology (Internal Medicine) | $68,241.42 |
| Lavanya Viswanathan | Houston, TX | Gastroenterology (Internal Medicine) | $64,076.62 |
| Bryan Curtin | Augusta, GA | Gastroenterology (Internal Medicine) | $57,341.06 |
| Susan Lucak | New York, NY | Gastroenterology (Internal Medicine) | $45,361.21 |
| Christina Hanson | Lone Tree, CO | Nurse Practitioner | $40,537.76 |
Prescribed Ibsrela?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.